TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. (TFFP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
tffp · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
TFF Pharmaceuticals, Inc.You TFFP | $0M | N/A | — | -$11.85 |
 Bellerophon Therapeutics, Inc. BLPH | $0M | N/A | — | -$2.08 |
 Histogen Inc. HSTO | $0M | N/A | — | -$3.31 |
 Akerna Corp. KERN | $0M | N/A | — | -$0.00 |
 Leafly Holdings, Inc. LFLY | $115M | N/A | — | -$2.30 |
 LakeShore Biopharma Co., Ltd LSB | $26M | N/A | — | -$0.94 |
 ProSomnus, Inc. OSA | $8M | N/A | — | -$1.49 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for TFF Pharmaceuticals, Inc. (TFFP) measures how much investors pay for each dollar of the company's trailing earnings. TFFP's current PE ratio of N/A is calculated by dividing its stock price of $0.07 by its TTM earnings per share of -$11.85.
Frequently asked questions
TFFP pe ratio · 6 questionsTFFP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.07 and TTM EPS of -$11.85. Data sourced from Financial Modeling Prep via TFFP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · TFF Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09